WHO ICTRP trial

ROCkeTS GEN V2 Study. Refining Ovarian Cancer Test Accuracy Scores: A test…

ISRCTN87528895 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN87528895
Public title ROCkeTS GEN V2 Study. Refining Ovarian Cancer Test Accuracy Scores: A test accuracy study to validate new risk scores in postmenopausal women with symptoms of suspected ovarian cancer
Scientific title Refining Ovarian Cancer Test Accuracy Scores: A test accuracy study to validate new risk scores in postmenopausal women with symptoms of suspected ovarian cancer. ROCkeTS GEN V2
Primary sponsor University of Birmingham
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries United Kingdom
Conditions Ovarian cancer Cancer
Interventions ROCkeTS GEN V2 study is a prospective single-arm cohort diagnostic accuracy study where all patients receive all tests, and accuracy of tests is evaluated against a gold standard of histology or 12-month outcome. A test accuracy study…
Registration date Feb 2, 2026
Target size 10
Secondary IDs CPMS: 70040, EDDRPG-May24/100002
Registry page isrctn.com

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations